a provider of outsourced clinical development and commercialization services to biopharmaceutical companies
Industry PharmaceuticalsOther
A.I.dvisor tells us that INCR and KMDA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and KMDA's prices will move in lockstep.
Ticker / NAME | Correlation To INCR | 1D Price Change % | ||
---|---|---|---|---|
INCR | 100% | +0.46% | ||
KMDA - INCR | 27% Poorly correlated | +0.52% | ||
SNDL - INCR | 25% Poorly correlated | +1.02% | ||
CGC - INCR | 23% Poorly correlated | +2.66% | ||
DVAX - INCR | 23% Poorly correlated | +1.56% | ||
SUPN - INCR | 23% Poorly correlated | -0.83% | ||
More |